Center-Authored Papers
Filters: Author is Desai, Kamal [Clear All Filters]
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Efficacy dilution in randomized placebo-controlled vaginal microbicide trials.. Emerging themes in epidemiology. 6:5. Abstract
.
2009.
A threshold method for immunological correlates of protection.. BMC medical research methodology. 13(1):29. Abstract
.
2013.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
A threshold method for immunological correlates of protection.. BMC medical research methodology. 13(1):29. Abstract
.
2013.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008.
A threshold method for immunological correlates of protection.. BMC medical research methodology. 13(1):29. Abstract
.
2013.
Efficacy dilution in randomized placebo-controlled vaginal microbicide trials.. Emerging themes in epidemiology. 6:5. Abstract
.
2009.
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
.
2008. Doing Business with Arnold Library
Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org
More About Arnold Library
Quick Links
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Pubmed
- Libguides
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)